PropertyValue
?:abstract
  • The total cases of novel corona virus (SARS-CoV-2) infections is more than one million and total deaths recorded is more than fifty thousand The research for developing vaccines and drugs against SARS-CoV-2 is going on in different parts of the world Aim of the present study was to identify potential drug candidates against SARS-CoV-2 from existing drugs using in silico molecular modeling and docking The targets for the present study was the spike protein and the main protease of SARS-CoV-2 The study was able to identify some drugs that can either bind to the spike protein receptor binding domain or the main protease of SARS-CoV-2 These include some of the antiviral drugs These drugs might have the potential to inhibit the infection and viral replication
is ?:annotates of
?:creator
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Drug Repurposing to Identify Therapeutics Against COVID 19 with SARS-Cov-2 Spike Glycoprotein and Main Protease as Targets: An in Silico Study
?:type
?:who_covidence_id
  • #342
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/7sujs9tc>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/7sujs9tc>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all